Four things to know:
1. Cases of young-onset colorectal cancer have jumped 51 percent since 1994, according to the National Cancer Institute.
2. The Young-Onset Colorectal Cancer Center focuses on providing tailored cancer care for younger patients. Clinicians genetically sequence each patient’s tumor to develop personalized care plans and address age-specific issues for patients, such as cancer therapies that affect fertility.
3. The center also serves as a research hub for scientists to better understand the growing incidence of young-onset colorectal cancer.
4. Boston-based Dana-Farber/Brigham and Women’s Cancer Center houses the new center within its existing Colon and Rectal Cancer Center.
More articles on clinical leadership & infection control:
How Mount Sinai increased hand hygiene compliance by 20%
Longer resident shifts don’t threaten patient safety, study finds
Tufts launches antimicrobial resistance research center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
